Inhibition of TNF-α synthesis with thalidomide for prevention of acute exacerbations and altering the natural history of multiple sclerosis
- 31 July 1999
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 53 (1) , 76-77
- https://doi.org/10.1054/mehy.1997.0719
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot studyBone Marrow Transplantation, 1997
- Thalidomide for the Treatment of Oral Aphthous Ulcers in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1997
- Mechanisms of Immune Injury in Multiple SclerosisBrain Pathology, 1996
- Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha.Proceedings of the National Academy of Sciences, 1995
- Thalidomide Inhibits Tumor Necrosis Factor- Production by Lipopolysaccharide- and Lipoarabinomannan-Stimulated Human Microglial CellsThe Journal of Infectious Diseases, 1995
- The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitisNature Medicine, 1995
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosisJournal of Neuroimmunology, 1992
- Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitroAnnals of Neurology, 1988
- Thalidomide and Congenital AbnormalitiesPublished by Springer Nature ,1962